Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0002012383-25-002600·BlackRock, Inc.
Schedule 13G ownership disclosure
Lexeo Therapeutics Inc
Common Stock · CUSIP: 52886X107
Event date: 2025-09-30
- Filing-level shares
- 2,168,444
- Percent of class
- 4.0%
- BlackRock, Inc.
Shares: 2,168,444 · Class: 4.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002012383-25-002600
- Form type
- SCHEDULE 13G/A
- Filer
- BlackRock, Inc.
- CIK
- CIK 2012383
- Filed
- Oct 17, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership